Related content

Differential Interactions of Cytochrome P450 3A5 and 3A4 with Chemotherapeutic Agent-Vincristine: A Comparative Molecular Dynamics Study

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 4, 2015-05 ,pp. : 475-483

Bentham Science Publishers

Access to resources Recommend Favorite

Eribulin mesylate: a promising new antineoplastic agent for locally advanced or metastatic breast cancer

By Cortes Javier   Lorca Rebeca  

Future Oncology, Vol. 7, Iss. 3, 2011-03 ,pp. : 355-364

Future Medicine

Access to resources Recommend Favorite

The pharmacological importance of cytochrome CYP3A4 in the palliation of symptoms: review and recommendations for avoiding adverse drug interactions

By Haddad Abdo   Davis Mellar   Lagman Ruth  

Supportive Care in Cancer, Vol. 15, Iss. 3, 2007-03 ,pp. : 251-257

Springer Publishing Company

Access to resources Recommend Favorite

Investigation into CYP3A4-mediated drug–drug interactions on midostaurin in healthy volunteers

By Dutreix Catherine   Munarini Florence   Lorenzo Sebastien   Roesel Johannes   Wang Yanfeng  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1223-1234

Springer Publishing Company

Access to resources Recommend Favorite

The effect of hydroxyurea on P-glycoprotein/BCRP-mediated transport and CYP3A metabolism of imatinib mesylate

By Oostendorp Roos   Marchetti Serena   Beijnen Jos   Mazzanti R.   Schellens Jan  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 6, 2007-06 ,pp. : 855-860

Springer Publishing Company

Access to resources Recommend Favorite